Rockefeller Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$589K Sell
21,361
-54,235
-72% -$1.5M ﹤0.01% 1513
2025
Q1
$2.14M Buy
75,596
+7,882
+12% +$223K 0.01% 1012
2024
Q4
$2.82M Sell
67,714
-491
-0.7% -$20.5K 0.01% 888
2024
Q3
$4.56M Sell
68,205
-108,516
-61% -$7.26M 0.01% 731
2024
Q2
$21M Buy
176,721
+2,198
+1% +$261K 0.06% 304
2024
Q1
$18.6M Buy
174,523
+4,465
+3% +$476K 0.05% 347
2023
Q4
$16.9M Buy
170,058
+514
+0.3% +$51.1K 0.06% 325
2023
Q3
$17.5M Buy
169,544
+10,895
+7% +$1.13M 0.07% 291
2023
Q2
$19.3M Buy
158,649
+38,203
+32% +$4.64M 0.07% 277
2023
Q1
$18.5M Buy
120,446
+1,962
+2% +$301K 0.08% 278
2022
Q4
$21.3M Buy
118,484
+76,551
+183% +$13.7M 0.11% 213
2022
Q3
$4.96M Buy
41,933
+4,000
+11% +$473K 0.03% 534
2022
Q2
$5.42M Buy
37,933
+1,922
+5% +$274K 0.03% 500
2022
Q1
$6.2M Buy
36,011
+12,222
+51% +$2.1M 0.03% 497
2021
Q4
$6.04M Buy
23,789
+1,305
+6% +$331K 0.03% 488
2021
Q3
$8.65M Buy
22,484
+3,043
+16% +$1.17M 0.05% 342
2021
Q2
$4.57M Sell
19,441
-3,518
-15% -$826K 0.03% 475
2021
Q1
$3.01M Buy
22,959
+1,810
+9% +$237K 0.02% 476
2020
Q4
$2.21M Sell
21,149
-4,775
-18% -$499K 0.02% 499
2020
Q3
$1.83M Sell
25,924
-4,138
-14% -$293K 0.02% 453
2020
Q2
$1.93M Sell
30,062
-14,220
-32% -$913K 0.02% 397
2020
Q1
$1.33M Buy
44,282
+44,100
+24,231% +$1.32M 0.02% 417
2019
Q4
$4K Buy
182
+82
+82% +$1.8K ﹤0.01% 1824
2019
Q3
$2K Buy
+100
New +$2K ﹤0.01% 1790